GlassScriptPhysician profile
Troy T Quiz
NPI 1245238575
$17,705.20
in general payments reported to CMS, 2019-2025
42 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,043 · 2020: $2,325 · 2021: $2,413 · 2022: $2,467 · 2023: $2,631 · 2024: $3,029 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,412 · Education: $45.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,411.79 |
| Education | $45.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,718.33 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,812.60 | 2020-2025 | |
| Novo Nordisk INC | $1,669.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,448.22 | 2019-2025 | Otezla, Repatha, Evenity |
| Sanofi-Aventis U.S. LLC | $1,207.13 | 2019-2023 | |
| Lilly USA, LLC | $1,006.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $867.05 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $680.00 | 2021-2025 | |
| Pfizer INC. | $667.28 | 2019-2025 | |
| Glaxosmithkline, LLC. | $654.17 | 2019-2024 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $603.47 | 2019-2025 | Trintellix |
| Abbott Laboratories | $431.03 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $358.53 | 2019-2023 | Steglatro, Belsomra, Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.83 | 2019-2025 | Jardiance |
| Allergan, INC. | $320.43 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Quiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.